financetom
Business
financetom
/
Business
/
Prairie Operating Plans to Drill First 8 Wells in August
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Prairie Operating Plans to Drill First 8 Wells in August
Jul 9, 2024 8:38 AM

11:20 AM EDT, 07/09/2024 (MT Newswires) -- Prairie Operating Company ( PROP ) said Tuesday it plans to begin drilling its first wells in August at eight sites targeting the Niobrara B and C formations of the Denver-Julesburg basin.

The company said it has contracted a drilling rig from Precision Drilling ( PDS ) and arranged for other oilfield services at the properties. Prairie is expecting to complete work on the new wells and start production by Q4, it said.

The company recently acquired the well locations through its Shelduck South bolt-on transaction.

Prairie shares were 0.9% lower in recent trading Tuesday.

Price: 9.21, Change: -0.08, Percent Change: -0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Teledyne To Acquire Micropac
BRIEF-Teledyne To Acquire Micropac
Nov 4, 2024
Nov 4 (Reuters) - Micropac Industries Inc ( MPAD ): * TELEDYNE TO ACQUIRE MICROPAC * MICROPAC INDUSTRIES INC ( MPAD ) - TELEDYNE TO ACQUIRE MICROPAC FOR $20.00 PER SHARE * MICROPAC INDUSTRIES INC ( MPAD ) - TRANSACTION VALUES MICROPAC AT APPROXIMATELY $57.3 MILLION Source text: Further company coverage: ...
What's Going On With Journey Medical Stock Today?
What's Going On With Journey Medical Stock Today?
Nov 4, 2024
Journey Medical ( DERM ) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea. What Happened: The FDA has approved Journey Medical’s Emrosi, formerly known as DFD-29, for the treatment of inflammatory lesions of rosacea in adults.  The approval was supported by positive data from...
BRIEF-Tokyo Lifestyle Announces Joint Venture With Crossing Limited To Expand Into Trading Card Retail Business
BRIEF-Tokyo Lifestyle Announces Joint Venture With Crossing Limited To Expand Into Trading Card Retail Business
Nov 4, 2024
Nov 4 (Reuters) - Tokyo Lifestyle Co Ltd ( TKLF ): * TOKYO LIFESTYLE CO., LTD. ( TKLF ) ANNOUNCES JOINT VENTURE WITH CROSSING LIMITED TO EXPAND INTO TRADING CARD RETAIL BUSINESS * TOKYO LIFESTYLE CO LTD ( TKLF ) - ENTERS 5-YEAR AGREEMENT WITH CROSSING LIMITED * TOKYO LIFESTYLE CO LTD ( TKLF ) - CO AND CROSSING LIMITED...
BRIEF-Boston Scientific Announces Agreement To Acquire Cortex
BRIEF-Boston Scientific Announces Agreement To Acquire Cortex
Nov 4, 2024
Nov 4 (Reuters) - Boston Scientific Corp ( BSX ): * BOSTON SCIENTIFIC ANNOUNCES AGREEMENT TO ACQUIRE CORTEX, INC. * BOSTON SCIENTIFIC CORP ( BSX ): SPECIFIC TERMS OF TRANSACTION HAVE NOT BEEN DISCLOSED. * BOSTON SCIENTIFIC CORP ( BSX ) - TRANSACTION EXPECTED TO BE SLIGHTLY DILUTIVE ON GAAP BASIS IN 2025 * BOSTON SCIENTIFIC CORP ( BSX )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved